Stockreport

Standard BioTools Announces Operational Restructuring Plan to Drive Long-Term Profitable Growth

Standard BioTools Inc.  (LAB) 
PDF Company expects to achieve $45-$50 million in annualized operating expense savings in fiscal 2025Management to discuss first quarter 2024 financial results, restructurin [Read more]